Host Interactions with Engineered T-cell Micropharmacies
Christopher M. Bourne(Memorial Sloan Kettering Cancer Center), David A. Scheinberg(Cornell University)
Cited by 5
Related Papers
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
|Journal of Clinical Investigation|2017|92
Selective Alpha-Particle Mediated Depletion of Tumor Vasculature with Vascular Normalization
|PLoS ONE|2007|48
Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
|Cancer Immunology Immunotherapy|2023|34